Drug · DIN 02403706
PREGABALIN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 20, 2021; first marketed March 27, 2013.
- Drug Identification Number (DIN)
- 02403706
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Pregabalin N02BF02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PREGABALIN | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 8, 2021: NOC 25638Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
- October 10, 2017: NOC 19896Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
- March 26, 2013: NOC 14244Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named PREGABALIN
- DIN 02396483 · Marketed
- DIN 02396505 · Marketed
- DIN 02396513 · Marketed
- DIN 02396521 · Marketed
- DIN 02396548 · Marketed
- DIN 02403692 · Marketed
- DIN 02403714 · Marketed
- DIN 02403722 · Marketed
- DIN 02403730 · Marketed
- DIN 02405539 · Marketed
- DIN 02405547 · Marketed
- DIN 02405555 · Marketed
- DIN 02405563 · Marketed
- DIN 02405598 · Marketed
- DIN 02474352 · Marketed
- DIN 02474360 · Marketed
- DIN 02474379 · Marketed
- DIN 02474387 · Marketed
- DIN 02376946 · Cancelled Pre Market
- DIN 02376954 · Cancelled Pre Market